Epstein-Barr virus-induced T cell lymphoma in solid organ transplant recipients

66Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Epstein-Barr virus (EBV) infection in transplant recipients can lead to lymphomas termed post-transplantation lymphoproliferative disorders (PTLDs). Most PTLDs are malignancies of B lymphocytes and are linked to EBV infection, but the rare T lymphocyte PTLDs have been inconsistently linked to EBV infection. Although the B lymphocyte is the main host cell of EBV, it has been suggested that T lymphocytes may also become infected by EBV. A review of EBV-induced PTLDs at our institution identified one of 61 cases that was restricted to T lymphocytes. Of 36 cases of T cell PTLD identified through a literature review, 21 were investigated for the presence of EBV, and eight (38%) were documented to be EBV-induced. We compared the features of EBV- positive and EBV-negative T cell PTLDs and concluded that cases of EBV- positive T cell PTLD have some distinctive clinical features.

Cite

CITATION STYLE

APA

Dockrell, D. H., Striekler, J. G., & Paya, C. V. (1998). Epstein-Barr virus-induced T cell lymphoma in solid organ transplant recipients. Clinical Infectious Diseases, 26(1), 180–182. https://doi.org/10.1086/516269

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free